1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Wen-Kai Weng: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma Autologous hematopoietic cell transplant (Auto-HCT), Allogeneic hematopoietic cell transplant (Allo-HCT), Cyclophosphamide - Blood Cancer, Multiple Myeloma | Phase 2 | Completed | Wen-Kai Weng | 63 | 2000-08-01 | 2018-01-18 |
Hematologic Neoplasms (1) · Multiple Myeloma (1)
Cyclophosphamide (1) · Cyclosporine (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Melphalan (1) · Mycophenolic Acid (1) · Whole-Body Irradiation (1)
United States (1)